PPPengyu Pan

Pengyu Pan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pengyu Pan has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Protective Effects of 3,4-Dihydropyrimidin-2(1 H )-one Derivatives on Oxidative Stress Injury following Subarachnoid Hemorrhage

    by Huansuo Ren, Kunyuan Zhu, Hong Qu, Youcheng Li, Wei Jiang, Wenqian Chen, Xuejun Chen, Guobiao Liang, Tengfei Mao, Pengyu Pan

    Subarachnoid hemorrhage (SAH), accounting for approximately 5% of all stroke cases, triggers hemorrhagic brain injury where early brain injury (EBI) emerges as a pivotal prognostic determinant. EBI is characterized by multiple pathophysiological processes including oxidative stress (OS), neuroinflammation, neuronal apoptosis, and blood-brain barrier (BBB) disruption following SAH. This study investigated the neuroprotective effects of 3,4-dihydropyrimidin-2(1H)-one derivatives (DHPMs) against neural dysfunction and EBI in a murine SAH model, compared with edaravone (EDA). We hypothesized that DHPMs alleviate SAH-induced neurological damage, dysfunction, and apoptosis through scavenging excess reactive oxygen species (ROS) generated post-SAH, a mechanistic premise systematically validated through experimental analyses. We hypothesized that male C57BL/6 mice weighing between 22 g and 30 g were arbitrarily classified into one of seven cohorts: sham, SAH, SAH + vehicle, SAH + DHPMs 50 mg/kg, SAH + DHPMs 300 mg/kg, SAH + DHPMs 500 mg/kg, and SAH + EDA 10 mg/kg. The intravascular threading method was utilized to induce SAH in the mice. DHPMs were intraperitoneally administered at 50 mg/kg, 300 mg/kg, and 500 mg/kg 15 min after SAH, while EDA was intraperitoneally provided at 10 mg/kg. The modified Garcia score (MGS) and balance beam test (BBT) were employed for behavioral activity assessment at 24 h and 72 h post-SAH, with neurological scores recorded for mice. Subsequently, mice were euthanized to evaluate SAH grade and severity, followed by determination of the optimal drug dosage according to the group exhibiting the most significant behavioral improvement. We computed the brain water content using the dry and wet protocol 24 h post-SAH, while Evans blue was employed to assess BBB leakage. Using Western blot, we also detected pathway-associated proteins, inflammation-related proteins, apoptosis-related proteins, and tight junction (TJ) proteins at the protein level in experimental SAH in mice. Frozen brain tissue sections of mice were prepared for immunofluorescence (IF) staining to observe the changes of microglia, astrocytes, and neurons before and after SAH administration in mice. Our experiment found that the intervention of 300 mg/kg DHPMs after SAH could improve the neurological score of mice, similar to the effects observed with EDA 10 mg/kg intervention. Additionally, DHPMs intervention was found to reduce brain edema and BBB damage 24 h post-SAH, surpassing the efficacy of EDA. Furthermore, the administration of 300 mg/kg DHPMs was linked to augmented Nrf2, apoptosis proteins Bax, Caspase-3, CHOP-1, inflammation proteins interleukin (IL)-1β, IL-18, TJ proteins Occludin, claudin-5, and zonulaoccludens-1 (ZO-1) protein expressions, and diminished heme oxygenase 1 (HO-1) and apoptosis protein Bcl-2 protein expressions. We demonstrated that DHPMs have the potential to safeguard neurological function, mitigate brain edema and BBB disruption, and alleviate OS, inflammation, and apoptosis following SAH.

  • Open Access

    PtTe2-alginate hydrogels for combined photothermal-chemodynamic cancer therapy by inducing cell apoptosis via modulation of TNF-α-related signaling pathways

    by Jiayao Tong, Jiaqi Qin, Jianghao Xing, Huansuo Ren, Peng Cao, Hui Wang, Pengyu Pan, Xianwen Wang, Haowei Xue


  • Open Access

    DDX3X Aggravates Neuronal Pyroptosis and Inhibits Autophagy via NLRP3 Inflammasome After Experimental Subarachnoid Hemorrhage

    by Guangzhi Hao, Yu Huan, Yuwei Han, Zuolin Shi, Xinyu Yang, Yushu Dong, Pengyu Pan, Guobiao Liang

    Neuronal cell death is considered the symbol of early brain injury after subarachnoid hemorrhage (SAH), but the mechanism was still unclear. DDX3X, a member of the DEAD-box helicase family, has a major effect on immune inflammation by mediating RNA metabolism. Recent studies report that DDX3X regulates the balance of NLRP3 inflammasome and stress granules in stress conditions, but the role of DDX3X in SAH is still unknown. Therefore, we conducted in vivo and in vitro experiments to investigate the role and mechanism of DDX3X in SAH. Western blot and immunofluorescence showed that SAH promoted DDX3X expression, especially in the cortical neurons. After upregulation of DDX3X, the NLRP3 inflammasome was activated and autophagy was inhibited, resulting in neurological dysfunction and damage to the blood–brain barrier. Further rescue experiments confirmed that DDX3X aggravated neuronal pyroptosis and inhibited autophagy via the NLRP3 inflammasome after SAH. Hence, DDX3X might be a potential therapeutic target for early brain injury of SAH. Graphical Abstract After SAH, DDX3X was activated in both in vivo and in vivo neurons. DDX3X aggravated neuronal pyroptosis and inhibited autophagy via NLRP3 inflammasome.

  • Open Access

    Epsin bioactive coating reduced in-stent intimal hyperplasia by promoting early phase reendothelialization and inhibiting smooth muscle cell proliferation

    by Wenxu Zhang, Hao Lin, Zechao Zhu, Kunyuan Zhu, Shijun Bi, Xinyu Yang, Guangzhi Hao, Dandan Gao, Da Huo, Shanshan Chen, et al.

    In recent years, interventional surgery has become a treatment for ischemic stroke due to its low risk of injury. However, the occurrence of restenosis hinders the long-term effectiveness and safety of stent implantation. At present, drug-eluting stents mainly prevent the stenosis of drug-eluting stents by inhibiting the proliferation of smooth muscle cells (SMCs). However, these drugs cause damage to endothelial cells (ECs), prevent timely re endothelialization of blood vessels, and increase the risk of late thrombosis and late restenosis. EPS-15-interacting protein 1 (Epsin1)- EPS-15-interacting protein 2 (Epsin2)-shrna coated stents have the potential to promote early endothelialization and inhibit restenosis, which contributes to the candidate development of novel drug coated stents. We found that the expression of Epsin was elevated in the mouse carotid artery ligation model, and the intimal hyperplasia(IH) could be reduced by intervening Epsin. Epsin in cultured endothelial cells was interfered to study proliferation and migration functions, and its role in cocultured endothelial cells and smooth muscle cells was evaluated. In addition, we explored the potential therapeutic benefits of inhibiting Epsin in a porcine model using scaffolds coated with plasmids containing Epsin short hairpin RNA (shRNA). Our study showed that the expression of Epsin1 and Epsin2 was elevated in the proliferative intima of mice, and the inhibition of Epsin reduced the proliferation of neointima in mice. The inhibition of Epsin led to enhanced proliferation and migration of endothelial cells, and maintained a healthy cell membrane potential. In cocultured cells, inhibition of Epsin resulted in reduced proliferation and migration of smooth muscle cells. In a porcine carotid artery model, Epsin shRNA coated scaffolds promoted early re endothelialization and reduced IH. These results suggest that Epsin plays a crucial role in endothelial and smooth muscle cell proliferation and migration functions, and its inhibition may be a potentially effective therapeutic strategy to prevent in stent stenosis.


  • Open Access

    Enhancing Th17 cells drainage through meningeal lymphatic vessels alleviate neuroinflammation after subarachnoid hemorrhage

    by Dandan Gao, Bin Zou, Kunyuan Zhu, Shijun Bi, Wenxu Zhang, Xinyu Yang, Jieyu Lai, Guobiao Liang, Pengyu Pan

    Subarachnoid hemorrhage (SAH) is a severe cerebrovascular disorder primarily caused by the rupture of aneurysm, which results in a high mortality rate and consequently imposes a significant burden on society. The occurrence of SAH initiates an immune response that further exacerbates brain damage. The acute inflammatory reaction subsequent to SAH plays a crucial role in determining the prognosis. Th17 cells, a subset of T cells, are related to the brain injury following SAH, and it is unclear how Th17 cells are cleared in the brain. Meningeal lymphatic vessels are a newly discovered intracranial fluid transport system that has been shown to drain large molecules and immune cells to deep cervical lymph nodes. There is limited understanding of the role of the meningeal lymphatic system in SAH. The objective of this research is to explore the impact and underlying mechanism of drainage Th17 cells by meningeal lymphatics on SAH. Treatments to manipulate meningeal lymphatic function and the CCR7-CCL21 pathway were administered, including laser ablation, injection of VEGF-C geneknockout, and protein injection. Mouse behavior was assessed using the balance beam experiment and the modified Garcia scoring system. Flow cytometry, enzyme-linked immunosorbent assays (ELISA), and immunofluorescence staining were used to study the impact of meningeal lymphatic on SAH drainage. Select patients with unruptured and ruptured aneurysms in our hospital as the control group and the SAH group, with 7 cases in each group. Peripheral blood and cerebrospinal fluid (CSF) samples were assessed by ELISA and flow cytometry. Mice with SAH showed substantial behavioral abnormalities and brain damage in which immune cells accumulated in the brain. Laser ablation of the meningeal lymphatic system or knockout of the CCR7 gene leads to Th17 cell aggregation in the meninges, resulting in a decreased neurological function score and increased levels of inflammatory factors. Injection of VEGF-C or CCL21 protein promotes Th17 cell drainage to lymph nodes, an increased neurological function score, and decreased levels of inflammatory factors. Clinical blood and CSF results showed that inflammatory factors in SAH group were significantly increased. The number of Th17 cells in the SAH group was significantly higher than the control group. Clinical results confirmed Th17 cells aggravated the level of neuroinflammation after SAH. This study shows that improving the drainage of Th17 cells by meningeal lymphatics via the CCR7-CCL21 pathway can reduce brain damage and improve behavior in the SAH mouse model. This could lead to new treatment options for SAH.


  • Open Access

    Edaravone dexborneol attenuates oxidative stress in experimental subarachnoid hemorrhage via Keap1/Nrf2 signaling pathway

    by Kunyuan Zhu, Shijun Bi, Zechao Zhu, Wenxu Zhang, Xinyu Yang, Jiashuo Li, Guobiao Liang, Chunyong Yu, Pengyu Pan

    Background: Subarachnoid hemorrhage (SAH) serves as a disease characterized by high incidence rate, which is exceedingly prevalent and severe. Presently, there is no unambiguous or efficacious intervention for the neurological impairment following SAH. Administering multi-targeted neuroprotective agents to reduce oxidative stress (OS) and neuroinflammation caused by early brain injury (EBI) has been demonstrated to improve neurological function and prognosis following SAH. Edaravone dexborneol (EDB), a novel multi targeted neuroprotective medication, combines four parts edaravone (EDA) with 1 part (+)-borneol in proportion. Clinical trials conducted in China have revealed during 2 days of acute ischemic stroke (AIS), early administration of EDB leads to improved therapeutic outcomes compared to treatment in EDA monotherapy. Currently, there is no clear evidence that EDB can effectively treat SAH, therefore, our study aims to investigate its potential therapeutic effects and mechanisms on EBI after SAH.Method: We used the intravascular threading method to establish a mouse model of SAH to explore whether EDA and EDB could produce anti-OS and anti-apoptosis effects. Behavioral assessment of mice was conducted using the balance beam experiment and the modified Garcia scoring system. Neuronal damage due to OS and Keap1/Nrf2 signaling pathway were detected through techniques of immunofluorescence, Western blotting, spectrophotometry. The group of EDA and EDB were injected intraperitoneally for 72 h after SAH.Results: The experiment results indicated that EDB lead to remarkably positive results by significantly enhancing neurological function, reducing blood-brain barrier (BBB) injury, and effectively inhibiting neuronal apoptosis after SAH. Further examination indicated EDB significantly reduced the expression of Keap1 and increased the expression of Nrf2, and it inhibited MDA, and enhanced SOD activity after SAH. These outcomes surpassed the effectiveness observed in EDA monotherapy. However, the application of ML385 reversed the anti-OS effects of EDB and EDA.Conclusion: Our experimental findings indicated that EDB could activate Keap1/Nrf2 signaling pathway to reduce OS damage, thereby protecting neurological function and enhancing behavioral abilities after SAH. These outcomes could facilitate the creation of new approaches for the clinical management of SAH.


  • Aloe-emodin from Sanhua Decoction inhibits neuroinflammation by regulating microglia polarization after subarachnoid hemorrhage

    by Hui Liu, Dan Guo, Jiao Wang, Wenxu Zhang, Zechao Zhu, Kunyuan Zhu, Shijun Bi, Pengyu Pan, Guobiao Liang


  • Open Access

    Chitosan-salvianolic acid B coating on the surface of nickel-titanium alloy inhibits proliferation of smooth muscle cells and promote endothelialization

    by Shijun Bi, Hao Lin, Kunyuan Zhu, Zechao Zhu, Wenxu Zhang, Xinyu Yang, Shanshan Chen, Jing Zhao, Meixia Liu, Pengyu Pan, et al.

    Introduction: Intracranial stents are of paramount importance in managing cerebrovascular disorders. Nevertheless, the currently employed drug-eluting stents, although effective in decreasing in-stent restenosis, might impede the re-endothelialization process within blood vessels, potentially leading to prolonged thrombosis development and restenosis over time.Methods: This study aims to construct a multifunctional bioactive coating to enhance the biocompatibility of the stents. Salvianolic acid B (SALB), a bioactive compound extracted from Salvia miltiorrhiza, exhibits potential for improving cardiovascular health. We utilized dopamine as the base and adhered chitosan-coated SALB microspheres onto nickel-titanium alloy flat plates, resulting in a multifunctional drug coating.Results: By encapsulating SALB within chitosan, the release period of SALB was effectively prolonged, as evidenced by the in vitro drug release curve showing sustained release over 28 days. The interaction between the drug coating and blood was examined through experiments on water contact angle, clotting time, and protein adsorption. Cellular experiments showed that the drug coating stimulates the proliferation, adhesion, and migration of human umbilical vein endothelial cells.Discussion: These findings indicate its potential to promote re-endothelialization. In addition, the bioactive coating effectively suppressed smooth muscle cells proliferation, adhesion, and migration, potentially reducing the occurrence of neointimal hyperplasia and restenosis. These findings emphasize the exceptional biocompatibility of the newly developed bioactive coating and demonstrate its potential clinical application as an innovative strategy to improve stent therapy efficacy. Thus, this coating holds great promise for the treatment of cerebrovascular disease.


  • SRY-related high-mobility-group box 4: Crucial regulators of the EMT in cancer

    by Xue Wu, Zhenlong Xin, Zheng Zou, Chenxi Lu, Zihao Yu, Sizhe Feng, Pengyu Pan, Guangzhi Hao, Yushu Dong, Yang Yang